RNAi for Therapeutic Market
RNAi for Therapeutic Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
RNAi for Therapeutic Market Size and Growth
The RNAi for Therapeutic market is rapidly growing, with a projected market size of $1.2 billion by 2025. Advances in RNAi technology have fueled the development of innovative therapeutics for a wide range of diseases. Key players in the market include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and Dicerna Pharmaceuticals.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Alnylam Pharmaceuticals
◍ Arbutus Biopharma (Tekmira)
◍ Arrowhead
◍ Dicerna Pharmaceuticals
◍ Mirna Therapeutics
◍ Quark Pharmaceuticals
◍ RXi Pharmaceuticals
◍ Silence Therapeutics
◍ Benitec Biopharma
◍ miRagen Therapeutics
◍ Sylentis
◍ Gradalis
◍ Sirnaomics
◍ Silenseed
The RNAi for Therapeutic Market has numerous players such as Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Arrowhead, and more. These companies utilize RNAi technology to develop innovative therapies for various diseases, contributing to the market's growth. Actual sales revenue figures (in million USD): Alnylam - 576.9, Arrowhead - 60.4, Mirna Therapeutics - 25.6. Request Sample Report
Market Segmentation
By Application
Cancer
Cardiovascular
HBV
Others
Request Sample Report
By Product
◍ siRNA ◍ miRNA ◍ shRNA ◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients